Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

The End of ACE Inhibitors? - Frankly Speaking Ep 253

The End of ACE Inhibitors? - Frankly Speaking Ep 253

FromFrankly Speaking About Family Medicine


The End of ACE Inhibitors? - Frankly Speaking Ep 253

FromFrankly Speaking About Family Medicine

ratings:
Length:
8 minutes
Released:
Dec 6, 2021
Format:
Podcast episode

Description

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-253
 
Overview: ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are both recommended as first-line treatments for hypertension. ACE inhibitors have known side effects, such as cough, that are frustrating for many patients, while ARBs appear to have less annoying side effects. This podcast will review a recently published retrospective, comparative cohort study comparing the effectiveness and safety of ACE inhibitors vs ARBs in the first-line treatment of hypertension.
 
Episode resource links:

Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667
 


ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248. doi: 10.1016/j.jacc.2017.11.006


Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato
Released:
Dec 6, 2021
Format:
Podcast episode

Titles in the series (100)

A weekly Podcast series covering newsworthy topics in primary care medicine.